- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03197428
Platelet-rich Plasma for Chronic Lateral Ankle Instability
April 2, 2019 updated by: Pei-Yuan Lee, MD
Efficacy of Platelet-rich Plasma in the Treatment of Chronic Lateral Ankle Instability
This study aims to evaluate the effect of platelet-rich plasma (PRP) on chronic lateral ankle instability by comparing the imaging and clinical outcomes between patients receiving PRP and those receiving whole blood during the modified Broström-Gould procedure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Chronic lateral ankle instability (CAI) in a common foot and ankle problem.
It has been linked to recurrent ankle pain, swelling, and even early degenerative change if not properly treated.
Lateral ligament reconstruction using modified Broström-Gould procedure is the mainstream in treatment of CAI.
Early mobilization is related to better functional outcome, and rapid healing of the repair is the key point to shorten the immobilization time.
Platelet-rich plasma (PRP) is a fraction of plasma that contains platelets and multiple growth factors concentrated at high level.
Because activated platelets have the potential to release growth factors, PRP has been clinically used to accelerate wound healing and tissue regeneration.
However, there is no conclusion regarding the efficacy of PRP on CAI.
This clinical trial will investigate the effect of PRP on CAI.
Eligible patients will be randomly assigned to receive PRP or whole blood during the modified Broström-Gould procedure.
The postoperative imaging and clinical outcomes will be compared and analyzed.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Changhua
-
Changhua City, Changhua, Taiwan, 500
- Show Chwan Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 20 and 60 years
- With diagnosis of chronic lateral ankle instability
Exclusion Criteria:
- Poor controlled diabetes
- Peripheral artery obstructive disease
- Skin or soft tissue infection at ankle
- With current or prior history of ankle disease, including degeneration arthritis, fracture, deformity, and cartilage disease.
- With prior history of ankle surgery
- With current or prior history of cancer
- With current or prior history of hematological disease
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: PRP group
15 patients will receive platelet-rich plasma gel applied during the modified Broström-Gould procedure for reconstructing lateral ligament.
|
Platelet-rich plasma gel applied during the modified Broström-Gould procedure for reconstructing lateral ligament
|
PLACEBO_COMPARATOR: Control group
15 patients will receive whole blood applied during the modified Broström-Gould procedure for reconstructing lateral ligament.
|
Whole blood applied during the modified Broström-Gould procedure for reconstructing lateral ligament
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3-month postoperative ankle function evaluated by AOFAS Ankle-Hindfoot score
Time Frame: 3-month postoperative
|
Ankle function is evaluated by AOFAS Ankle-Hindfoot score
|
3-month postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
3-month postoperative ankle pain evaluated by visual analogue scale
Time Frame: 3-month postoperative
|
Ankle pain is evaluated by visual analogue scale
|
3-month postoperative
|
3-month postoperative anterior displacement of ankle evaluated by stress radiographs of anterior drawer test
Time Frame: 3-month postoperative
|
Anterior displacement is evaluated by the anterior displacement of the talus relative to the tibia on stress radiographs of anterior drawer test.
|
3-month postoperative
|
3-month postoperative lateral tilt of ankle evaluated by stress radiographs of talar tilt test
Time Frame: 3-month postoperative
|
Lateral tilt of ankle is evaluated by stress radiographs of talar tilt test.
|
3-month postoperative
|
Percentage of patients with healed ligament evaluated by MRI
Time Frame: 3-month postoperative
|
Healing condition of ligament is assessed by MRI.
|
3-month postoperative
|
Percentage of patients with healed ligament evaluated by second look arthroscopy
Time Frame: 3-month postoperative
|
Healing condition of ligament is assessed by second look arthroscopy.
|
3-month postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 5, 2016
Primary Completion (ACTUAL)
January 12, 2019
Study Completion (ACTUAL)
January 31, 2019
Study Registration Dates
First Submitted
April 13, 2017
First Submitted That Met QC Criteria
June 21, 2017
First Posted (ACTUAL)
June 23, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 4, 2019
Last Update Submitted That Met QC Criteria
April 2, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RA-16026-RD-105066
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Platelet-rich Plasma
-
Peterson, Noel, N.D.CompletedPlatelet Rich Plasma ProductionUnited States
-
Chang Gung Memorial HospitalCompleted
-
Harrison, Theodore, M.D.Unknown
-
Assiut UniversityUnknownAutologous Platelet Rich Plasma Effect on Bone Healing
-
Germans Trias i Pujol HospitalCompletedEvaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection TechniquesEndoscopic Submucosal Dissection | Platelet-rich Plasma | Endoscopic Mucosal ResectionSpain
-
Chang Gung Memorial HospitalNot yet recruitingAging | Platelet-Rich PlasmaTaiwan
-
University of MalagaUnknown
-
University of Colorado, DenverCompletedPlatelet-Rich PlasmaUnited States
-
Rajavithi HospitalRecruitingAutologous Platelet-rich Plasma Supplement | Sperm Cryopreservation | Post-cryopreserved Sperm Quality | Semen AnalysisThailand
Clinical Trials on Platelet-rich plasma
-
Stanford UniversityPartnership for Clean CompetitionCompletedRheumatic Diseases | TendinopathyUnited States
-
VivaTech International, Inc.RecruitingOsteoarthritisUnited States
-
Genesis Athens ClinicNational and Kapodistrian University of AthensRecruitingMenopause, Premature | Menopausal Syndrome | Premature Ovarian Failure | Ovarian Failure, Premature | Menopause Related ConditionsGreece
-
Cardenal Herrera UniversityCompletedCarpal Tunnel SyndromeSpain
-
Damascus UniversityCompletedBone ResorptionSyrian Arab Republic
-
Rajavithi HospitalRecruitingAutologous Platelet-rich Plasma Supplement | Sperm Cryopreservation | Post-cryopreserved Sperm Quality | Semen AnalysisThailand
-
Peking University Third HospitalRecruiting
-
Matthew GettmanCompleted
-
Sutherland Medical CenterActive, not recruitingRotator Cuff Tears | Rotator Cuff TendinosisPoland
-
EgymedicalpediaAl-Azhar UniversityCompletedUrinary Incontinence | Stress Urinary IncontinenceEgypt